2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Highlights on Targeted Therapy in Early Stage EGFR+ NSCLC: Adjuvant Osimertinib, Adjuvant EGFR TKI Gefitinib vs. Standard Chemo

By 2020 ASCO Virtual Direct™ Highlights FEATURING Millie Das
By 2020 ASCO Virtual Direct™ Highlights FEATURING Millie Das
0 views
September 22, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
Lung
21:58
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Targeted Therapy in Early Stage EGFR+ NSCLC:…

Feat. M. Das
06:43
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on IO in NSCLC: Does Neoadjuvant Durvalumab Add Va…

Feat. M. Das
05:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on KEAP1/NFE2L2 Mutations in Localized NSCLC: Can G…

Feat. M. Das